ArticleRheumatology and therapy2021

Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States.

Martin Bergman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.